SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001437749-17-013417
Filing Date
2017-08-01
Accepted
2017-08-01 07:06:34
Documents
4
Period of Report
2017-08-01
Items
Item 2.02: Results of Operations and Financial Condition
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K acrx20170731_8k.htm 8-K 28966
2 EXHIBIT 99.1 ex99-1.htm EX-99.1 149794
3 EXHIBIT 99.2 ex99-2.htm EX-99.2 20663
4 logo.jpg GRAPHIC 5541
  Complete submission text file 0001437749-17-013417.txt   208295
Mailing Address 351 GALVESTON DRIVE REDWOOD CITY CA 94063
Business Address 351 GALVESTON DRIVE REDWOOD CITY CA 94063 650-216-3500
ACELRX PHARMACEUTICALS INC (Filer) CIK: 0001427925 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35068 | Film No.: 17994683
SIC: 2834 Pharmaceutical Preparations